[1]
“New-Onset Blepharitis in a Patient Treated With Secukinumab for Severe Psoriasis ”, Dermatol Pract Concept, vol. 14, no. 3, p. e2024185, Jul. 2024, doi: 10.5826/dpc.1403a185.